Literature DB >> 18425861

Antibiotics for acute maxillary sinusitis.

Anneli Ahovuo-Saloranta1, Oleg V Borisenko, Niina Kovanen, Helena Varonen, Ulla-Maija Rautakorpi, John W Williams, Marjukka Mäkelä.   

Abstract

BACKGROUND: Expert opinions vary on the appropriate role of antibiotics for sinusitis, one of the most commonly diagnosed conditions among adults in ambulatory care.
OBJECTIVES: We examined whether antibiotics are effective in treating acute sinusitis, and if so, which antibiotic classes are the most effective. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, 2007, Issue 3); MEDLINE (1950 to May 2007) and EMBASE (1974 to June 2007). SELECTION CRITERIA: Randomized controlled trials (RCTs) comparing antibiotics with placebo or antibiotics from different classes for acute maxillary sinusitis in adults. We included trials with clinically diagnosed acute sinusitis, whether or not confirmed by radiography or bacterial culture. DATA COLLECTION AND ANALYSIS: At least two review authors independently screened search results, extracted data and quality assessed trials. Risk ratios (RR) were calculated for differences in the intervention and control groups to see whether or not the treatment was a failure. In meta-analysing the placebo-controlled studies, the data across antibiotic classes were combined. Primary outcomes were the clinical failure rates at 7 to 15 days and 16 to 60 days follow up. MAIN
RESULTS: Fifty-seven studies were included in the review; six placebo-controlled studies and 51 studies comparing different classes of antibiotics. Five studies involving 631 participants provided data for comparison of antibiotics to placebo, when clinical failure was defined as a lack of cure or improvement at 7 to 15 days follow up. These studies found a slight statistical difference in favor of antibiotics, compared to placebo, with a pooled RR of 0.66 (95% confidence interval (CI) 0.44 to 0.98). However, the clinical significance of the result is equivocal, also considering that cure or improvement rate was high in both the placebo group (80%) and the antibiotic group (90%). Based on six studies, when clinical failure was defined as a lack of total cure, there was significant difference in favor of antibiotics compared to placebo with a pooled RR of 0.74 (95% CI 0.65 to 0.84) at 7 to 15 days follow up. None of the antibiotic preparations was superior to each other. AUTHORS'
CONCLUSIONS: Antibiotics have a small treatment effect in patients with uncomplicated acute sinusitis in a primary care setting with symptoms for more than seven days. However, 80% of participants treated without antibiotics improve within two weeks. Clinicians need to weigh the small benefits of antibiotic treatment against the potential for adverse effects at both the individual and general population level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425861     DOI: 10.1002/14651858.CD000243.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  27 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Acute post-operative rhinosinusitis following endonasal dacryocystorhinostomy.

Authors:  P N Shams; D Selva
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

3.  A guide to the management of acute rhinosinusitis in primary care: management strategy based on best evidence and recent European guidelines.

Authors:  Neil Foden; Christopher Burgess; Kathryn Shepherd; Robert Almeyda
Journal:  Br J Gen Pract       Date:  2013-11       Impact factor: 5.386

4.  Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial.

Authors:  Roderick P Venekamp; Marc J M Bonten; Maroeska M Rovers; Theo J M Verheij; Alfred P E Sachs
Journal:  CMAJ       Date:  2012-08-07       Impact factor: 8.262

5.  PURLs: Rethinking antibiotics for sinusitis: again.

Authors:  Christopher Boisselle; Kate Rowland
Journal:  J Fam Pract       Date:  2012-10       Impact factor: 0.493

Review 6.  Canadian guidelines for acute bacterial rhinosinusitis: clinical summary.

Authors:  Alan Kaplan
Journal:  Can Fam Physician       Date:  2014-03       Impact factor: 3.275

7.  Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.

Authors:  Paul K Keith; Andrzej Dymek; Oliver Pfaar; Wytske Fokkens; Suyong Yun Kirby; Wei Wu; Cindy Garris; Nazli Topors; Laurie A Lee
Journal:  Prim Care Respir J       Date:  2012-09

8.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

9.  Amoxicillin for acute rhinosinusitis: a randomized controlled trial.

Authors:  Jane M Garbutt; Christina Banister; Edward Spitznagel; Jay F Piccirillo
Journal:  JAMA       Date:  2012-02-15       Impact factor: 56.272

Review 10.  The prevalence of bacterial infection in acute rhinosinusitis: a Systematic review and meta-analysis.

Authors:  Stephanie S Smith; Elisabeth H Ference; Charlesnika T Evans; Bruce K Tan; Robert C Kern; Rakesh K Chandra
Journal:  Laryngoscope       Date:  2014-09-17       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.